vimarsana.com
Home
Live Updates
IBio Further Expands Tech Stack with ShieldTx™; Enhan
IBio Further Expands Tech Stack with ShieldTx™; Enhan
IBio Further Expands Tech Stack with ShieldTx™; Enhances Immuno-Oncology Development Pipeline with Conditionally Activated MUC16xCD3 Bispecific
- ShieldTx potentially increases safety and developability of therapeutic antibodies for difficult targets and modes of action - BRYAN, Texas and SAN DIEGO, Nov. 01, 2023 -- iBio, Inc. today...
Related Keywords
United States ,
Texas ,
American ,
Matt Greving ,
Susan Thomas ,
Stephen Kilmer ,
Martin Brenner ,
Globenewswire Inc ,
Bio Inc ,
Company Annual Report On Form ,
While The Company ,
Drug Discovery Platform ,
Epitope Steering ,
Machine Learning ,
Platform Technologies ,
Chief Executive Officer ,
Chief Scientific Officer ,
Biological Therapy ,
Annual Report ,
Markets ,